390P Impact of age on treatment strategies in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): A prespecified subgroup analysis of the GERCOR-PRODIGE STRATEGIC-1 phase III study

Autor: Carola, E., Chibaudel, B., Boulahssass, R., Dourthe, L.M., André, T., Henriques, J., Bourgeois, V., Etienne, P-L., Desrame, J., Dupuis, O., Baba-Hamed, N., Auby, D., Louvet, C., Maillard, E., Tournigand, C., Garcia-Larnicol, M-L., Shacham Shmueli, E., Bird, B.H., Ghiringhelli, F., de Gramont, A.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S715-S716
Databáze: ScienceDirect